School of Medicine

Wayne State University School of Medicine

Welcome

karmanos cancer institute The Hematology/Oncology Division of Internal Medicine is made up of a 32-physician staff.

Our services consist of:

  • Benign Hematology (sickle cell, red cell, white cell, hemostasis)
  • Malignant Hematology (leukemia, lymphoma, myeloma)
  • Bone Marrow Transplants

Oncology is made up of Breast, GI, GU, Head & Neck, Lung, Sarcoma, and Melanoma.

Multidisciplinary teams are the backbone of clinical care. They provide prospective evaluation and recommendations for diagnosis and therapy. Presentations regarding patients are made at a weekly patient management conference as well as educational conference.

The division is active in clinical trials research, as well as government funded research. It has a national reputation for academic excellence, research and clinical quality. Wayne State University, The Detroit Medical Center and Karmanos Cancer Institute are its clinical and academic affiliates. The division is a unique, urban-based, culturally-diverse, integrated system of research, patient care and education.

Its strongest affiliation is with the Karmanos Cancer Institute which is one of 15 comprehensive cancer centers in the U.S. All institutions are united by a common commitment to cancer-related concerns that affect the community. The Comprehensive Cancer Center mission is the prevention and cure of cancer. The Hematology/Oncology Division believes its programs allow cancer-related health concerns in the community to be addressed.

Mission:
The Division of Hematology/Oncology is within the Department of Medicine at Wayne State University and the Barbara Ann Karmanos Cancer Institute. It is an urban based program and is dedicated to patient care, research and education in the area of cancer. The Karmanos Cancer Center is a hospital dedicated entirely to cancer. We work with the Karmanos Cancer Institute to become a leader in integrating world class cancer physicians, researchers and educators in programs that advance our knowledge of cancer. We are committed to excellence in patient care, pursuing research efforts through NIH, foundations or industrial clinical studies, establishing new standards of clinical care, working in multidisciplinary teams and collaborating with other institutions in our research efforts.